Seelos Therapeutics Inc
F:NXEN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Seelos Therapeutics Inc
F:NXEN
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NXEN's stock price target?
Not Available
NXEN does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Seelos Therapeutics Inc?
Projected CAGR
263%
Over the last 8 years, the compound annual growth rate for Revenue has been -9%. The projected CAGR for the next 2 years is 263%.